Active Ingredient(s):Clevidipine Butyrate FDA Approved: * August 1, 2008 Pharm Company: *MEDICINES CO Category:Blood Pressure
Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable. Clevidipine is used IV only and practitioners titrate this drug to lower blood pressure. It has a half-life of approximately one minute. It is rapidly inactivated by esterases.
It was approved by the United States Food and Drug Administration on August 1, 2008.
1 Basic chemical and ...
* May have multiple approval dates, manufacturers, or labelers.